Pfizer's CEO certainly thinks so. In a TV interview, Bourla said: "Pfizer, when it plays, plays big. And we will -- as we did in COVID, as we did with Lipitor, as we did with ... Viagra, as we did ...

A recent state-of-the-art review highlights that Cardiovascular disease (CVD) and CV risk factors are frequent in patients ...

Pfizer stock offers 30% upside with strong non-COVID franchises, margin expansion, and pipeline potential. Click here to read ...

As someone who played it during its early access period, I was immediately surprised by how much Grounded has evolved for its 1.0 launch. It feels like it’s not only fulfilled the potential of its ...

Note: As the Xbox Series X turns one year old, we've updated this review to reflect the current state of Microsoft's console, including the expansion of Game Pass and cloud gaming services. From the ...

The staff of The New York Times Book Review choose the year’s top fiction and nonfiction. Need a last-minute holiday gift? Try one of these recent releases. Our critic A.O. Scott breaks down a scene ...

Learn about the benefits of taking vitamin D and vitamin K2 together. Discover how they benefit bone and heart health.

The staff of The New York Times Book Review choose the year’s top fiction and nonfiction. “American Canto,” published amid a scandal over the journalist’s alleged romantic entanglements with ...

In September 2025, a sweeping recall of atorvastatin—the nation's most-prescribed cholesterol-lowering drug—sent shockwaves through the American healthcare system. The U.S. Food and Drug ...

For decades, creating a large, glasses-free 3D display that looks like a real window has been a challenge because screens broadcast image information wastefully. Artificial intelligence has now been ...

Concomitant medications are emerging as a modifiable prognostic factor for immune checkpoint inhibitor treatment outcomes. This Review by Stone et al. highlights the potential immunomodulatory ...